2nd Quarter - Report

RICCHETTI INCORPORATED for SANOFI-AVENTIS U S INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

Issues related to compounding of veterinary drugs for animals.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform, extension of the R&D tax credit.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues related to patent litigation reforms.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Economics/Economic Development ECN

Issues related to the Global Investment in American Jobs Act of 2013.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to school access to emergency epinephrine; Outreach regarding the play-4 health program; Issues addressed in HR1919 (Safeguarding America's Pharmaceuticals Act of 2013).

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1919 (113th)

Medicare/Medicaid MMM

Issues related to pharmaceutical reimbursement; Issues related to the expansion of Medicaid drug rebate; Issues related to the repeal if IPAB; Issues addressed in the Medicare Better Health Rewards Program Act of 2013; Issues related to coverage and reimbursement for those who are covered by Medicare/Medicaid; Issues related to the operation of the 340B program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.